---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-063025"
form_type: "8-K"
ticker: "CTKB"
cik: "0001831915"
company_name: "Cytek Biosciences, Inc."
filed_at: "2022-03-02T23:59:59+00:00"
generated_at: "2026-06-27T02:34:31.175691+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cytek sets 2022 executive comp: salaries, bonuses, equity grants

## Summary
- CEO Wenbin Jiang: 2022 base salary $545,000, target bonus 80% of base.
- CTO Ming Yan: base $400,000, target bonus 50%; CFO Patrik Jeanmonod: base $385,000, target 50%.
- Equity grants: CEO 163,158 options + 108,137 RSUs; CTO 47,841 options + 31,708 RSUs; CFO 42,310 options + 28,042 RSUs.
- Options exercise price $13.64, vesting over 4 years; RSUs vest quarterly over 4 years.
- 2021 cash bonuses: CEO $163,687, CTO $134,451, CFO $106,492.

## SEC filing metadata
- accession: 0001193125-22-063025
- form_type: 8-K
- ticker: CTKB
- cik: 0001831915
- company_name: Cytek Biosciences, Inc.
- filed_at: 2022-03-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831915/000119312522063025/0001193125-22-063025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831915/000119312522063025/d214612d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-063025
- JSON: https://secwatch.observer/filing/0001193125-22-063025.json
- Plain text: https://secwatch.observer/filing/0001193125-22-063025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.